Manpreet Singh
Child & Adolescent Psychiatry Sacramento, CA Medical Doctor
NPI 1093888208 CMS profile 622181
2230 Stockton Blvd, Sacramento, CA 95817
General payments
$103,670
Research payments
$8,127
Ownership & investment interest
$0
Research they led as principal investigator
$134,711
Through program year 2025, Manpreet Singh of Sacramento, CA is reported in the CMS Open Payments database as having received $103,670 across 120 general payments and $8,127 in research payments paid to them. Separately, studies naming them as principal investigator received $134,711 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 99th percentile of Child & Adolescent Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
8 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $62,252 | 58 | |
| 2024 | General | $5,625 | 10 | |
| 2024 | Research | $7,512 | 7 | |
| 2023 | General | $9,934 | 17 | |
| 2022 | General | $24,395 | 30 | |
| 2020 | General | $1,402 | 3 | |
| 2019 | General | $63 | 2 | |
| 2019 | Research | $615 | 1 |
Beside peers
- Manpreet Singh
- Child & Adolescent Psychiatry median
- Middle half of Child & Adolescent Psychiatry
- National median
In program year 2025, general payments to Manpreet Singh were reported at $62,252. Among 1,601 Child & Adolescent Psychiatry profiles paid that year, the median was $132 and the middle half received between $41 and $474.
Show as a table
| Year | Manpreet Singh | Child & Adolescent Psychiatry median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $63 | $129 | $42–$419 | $163 |
| 2020 | $1,402 | $81 | $28–$226 | $114 |
| 2021 | $0 | $115 | $31–$326 | $132 |
| 2022 | $24,395 | $124 | $40–$382 | $149 |
| 2023 | $9,934 | $130 | $45–$420 | $160 |
| 2024 | $5,625 | $141 | $42–$490 | $164 |
| 2025 | $62,252 | $132 | $41–$474 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
128 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Child & Adolescent Psychiatry in California
Kevin Cox
Child & Adolescent Psychiatry · Ojai, CA
Sukhjit Brar
Child & Adolescent Psychiatry · Fresno, CA
Ihab Soliman
Child & Adolescent Psychiatry · Corona Del Mar, CA
Syed Naqvi
Child & Adolescent Psychiatry · Los Angeles, CA
Ellen Heyneman
Child & Adolescent Psychiatry · San Diego, CA
Mark McDonald
Child & Adolescent Psychiatry · Los Angeles, CA
Related records
Child & Adolescent Psychiatry in California
Practitioners in the same specialty and state, ranked by reported value.
All Child & Adolescent Psychiatry
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.